Pharmaceutical Commerce

JULY 1, 2025

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how patient and caregiver insights shape drug development, regulatory decisions, and payer considerations in rare diseases.

Drug Development 52

Drug Development 52

STAT

NOVEMBER 27, 2024

WASHINGTON — Legislation targeting Chinese biotechnology companies caused a ruckus early this year. None of that may matter if Congress doesn’t pass it in December. The BIOSECURE Act would restrict U.S.

Drug Development 317

Drug Development 317

STAT

FEBRUARY 20, 2025

In ongoing trials of Eli Lilly’s next-generation obesity drug, several trial participants are running into an issue they never expected: They are losing too much weight. One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs like Wegovy or Zepbound.

Drug Development 363

Drug Development 363

FDA Law Blog: Biosimilars

APRIL 8, 2025

Leading FDAs implementationof the Drug Competition Action Plan (DCAP). The DCAP was an initiative launched in 2017 to remove barriers to generic drug development, approval, and market entry (see our previous post here ). facilitating the twice annual updates to the Off-Patent, Off-Exclusivity List ).

Documentation 144

Documentation Labelling Drug Development 144

PharmaVoice

JULY 1, 2025

For example, the company engages its patient advisory councils “on topics across the full continuum of drug development, from discovery to commercialization.” Now, she’s developing ways to operationalize the collection of patient stories to infuse them into every aspect of the business.

Drug Development 130

Drug Development 130

STAT

JANUARY 13, 2025

Health data company Truveta said Monday it’s partnering with health systems and drugmakers to launch the Truveta Genome Project , a database of genetic data that is expected to accelerate personalized medicine and help discover new drugs. 

Medical Records 333

Medical Records Pharmaceutical Companies Pharmaceutical Companies Drug Development 333

STAT

JANUARY 13, 2025

Johnson & Johnson said Monday it would buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of large drugmakers’ reentry into neuroscience and a sizable purchase that will provide a boost as the industry gathers for one of its largest events of the year.

Drug Development 331

Drug Development 331

STAT

APRIL 1, 2025

spending on prescription drugs was almost $800 billion. Although low-cost generic drugs filled 91% of all prescriptions, the 9% of prescriptions filled with a branded medicine accounted for 84% of drug spending. In 2024, total U.S.

Prescription Filling 226

Prescription Filling Drug Pricing Drug Development 226

STAT

DECEMBER 20, 2024

Novo Nordisk’s next-generation obesity candidate led patients to lose a substantial amount of weight in a pivotal study but fell short of expectations, results that cast into doubt the future competitiveness of the company in the booming weight loss market.

Drug Development 344

Drug Development 344

European Pharmaceutical Review

JUNE 19, 2025

1,2 EMA’s draft reflection paper – implications for drug developers and manufacturers The proposed tailored approach offers opportunities for developers and manufacturers. In these cases, traditional clinical trials remain indispensable for ensuring patient safety and product efficacy.

Biosimilars 97

Biosimilars Packaging Documentation Drug Development 97

STAT

JANUARY 10, 2025

Industry-wide, AI tools are reducing drug development time by as much as  10X and bringing greater efficiencies and momentum to the most  time-consuming pharma process  of all: clinical trials. The good news: AI is starting to unlock the progress the industry needs. Continue to STAT+ to read the full story…

Drug Development 298

Drug Development 298

STAT

JANUARY 14, 2025

And the findings may provide further impetus for legislative action to curb practices that critics say contribute to the rising cost of prescription drugs. For the second time in less than a year, the U.S.

Drug Pricing 359

Drug Pricing Drug Development 359

STAT

MAY 15, 2025

The discussion wove notes of caution into an otherwise hopeful collection of conversations about the use of such technology in medical care and drug development. 

Communication 288

Communication Drug Development 288

Express Pharma

JULY 8, 2025

Dr Mahesh Bhalgat, Group CEO and Managing Director, Veeda Clinical Research Limited, said, “Our partnership will transform Veeda into an AI-driven oncology drug development organisation, meeting the growing demand for diversity in clinical trials, which is in line with the expectations of regulators and pharmaceutical companies.

Pharmaceutical Companies 100

Pharmaceutical Companies Pharmaceutical Companies Drug Development 100

STAT

JANUARY 8, 2025

SAN FRANCISCO — Next week brings the return of the J.P. Morgan Healthcare Conference, and with it another fabled opportunity for companies in the industry to court possible mergers, acquisitions, and licensing deals.

Drug Development 363

Drug Development 363

Pharmaceutical Technology

JUNE 26, 2025

Particularly beneficial in the early drug discovery phase, AI can help identify potential drug targets more effectively than traditional methods, accelerating the initial stages of drug development by quickly sifting through large volumes of data.

Compounding 86

Compounding Drug Development Communication Packaging 86

STAT

MARCH 5, 2025

Jazz Pharmaceuticals said Wednesday it would spend nearly $1 billion to buy Chimerix and its experimental pill for a devastating brain tumor that primarily affects children and young adults. The tumor, known as diffuse midline glioma, or DMG (and sometimes as DIPG depending on where it’s found), has flummoxed researchers for decades.

Chemotherapy 211

Chemotherapy Drug Development 211

Express Pharma

JULY 15, 2025

The framework introduces 80 sector-agnostic and 27 healthcare sector-specific indicators, offering a method to assess risks such as biomedical waste, antimicrobial resistance, and unequal access to care, while also identifying opportunities in areas like green hospital infrastructure, digital health, and affordable drug development.

Hospitals 59

Hospitals Packaging Pharmaceutical Companies Pharmaceutical Companies 59

Drug Patent Watch

JULY 10, 2025

In a recent study, researchers at [link] demonstrated the power of precision and reproducibility in generic drug development, showcasing a 95% success rate in replicating complex formulations. At the heart of the matter lies a delicate balance of precision and reproducibility. But what does this mean for the future of healthcare?

Drug Development 47

Drug Development 47

STAT

NOVEMBER 20, 2024

Schrödinger CEO Ramy Farid wants you to know that his company isn’t an AI company…but he’ll call it that if you want to. The company, founded in 1990, started out by making software that used the basic laws of physics to laboriously and exactly predict how molecules will interact with each other in space.

Drug Development 353

Drug Development 353

Express Pharma

JUNE 17, 2025

The process is essential in protein engineering, particularly in drug development, where proteins must bind to specific biological targets. Inverse protein folding involves identifying amino acid sequences that form a desired 3D protein structure.

Drug Development 98

Drug Development 98

Pharmaceutical Technology

JUNE 24, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in Harbour BioMed partners Otsuka on new T-cell therapy Madrigal poised to enter European MASH market after CHMP endorsement Themes Sections Artificial Intelligence Cloud Corporate Governance (..)

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Packaging Biosimilars Pharmaceutical Companies 52

PharmaTech

JUNE 19, 2025

link] Recent Videos Related Content FDA Voucher Program Provides Shorter Drug Application Review Time Susan Haigney June 18th 2025 Article The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for shortened drug approval review time.

Dosage 59

Dosage Drug Development Packaging Communication 59

Pharmaceutical Commerce

JUNE 27, 2025

Dipanwita Das, CEO and co-founder of Sorcero, chats with Pharma Commerce to dig into the evolving drug development landscape, being regulatorily compliant, and the rapid advancements in artificial intelligence.

Drug Development 59

Drug Development 59

STAT

DECEMBER 10, 2024

Fox Foundation’s annual meeting in New York — came from an unlikely source: Koneksa Health, which helps drug developers use smartphone apps and wearables to study whether their treatments work. But amid all the jostling to find the next use case for GLP-1s, the proposition in October — the day before the Michael J.

Diabetes 306

Diabetes Drug Development 306

Pharma Leaders

JULY 2, 2025

Bridging the Information Gap There’s a growing information gap between drug developers, doctors, and patients. Old-school pamphlets are being replaced by digital content to keep pace with both in-person and virtual care. Medical knowledge is expanding rapidly – doubling every 17 years!

Communication 40

Communication Drug Development 40

Pharmacy Times

JUNE 23, 2025

CMS is issuing unique J-codes for 505(b)(2) drugs, classifying them as sole-source products if not therapeutically equivalent. This pathway reduces submission denial risk, accelerates drug development, and offers potential market exclusivity for up to 7 years.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

STAT

NOVEMBER 26, 2024

New data from a mid-stage study of an Amgen obesity drug showed that it helped participants lose a substantial amount of weight, but questions about how competitive it could be appear to be shaping the response to the news, with the company’s share price falling on the announcement. 

Diabetes 330

Diabetes Drug Development 330

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GATC’s MAT platform identifies potential new drugs and provides comprehensive analytic reports. Lisata Therapeutics has formed a strategic partnership with GATC Health to advance AI-driven drug discovery and development.

Drug Development 52

Drug Development Communication Hospitals Packaging 52

Putting Patients First Blog

JUNE 26, 2025

13 Skylar Jeremias, “The IRA’s Unintended Consequences for Drug Pricing and Coverage,” The American Journal of Managed Care , April 2, 2025, [link] www.ajmc.com/view/the-ira-s-unintended-consequences- for-drug-pricing-and-coverage. Food and Drug Administration, FDA Patient-Focused Drug Development Guidance Series , March 21, 2025.

Drug Pricing 52

Drug Pricing Communication Drug Development Documentation 52

PharmaVoice

JULY 9, 2025

Simone Steiner, CTO, Transgene Permission granted by Trangene “In drug development the risks are high, and for anyone who has been in the industry for a period of time, they are likely to have experienced such failures,” Steiner said.

Vaccines 179

Vaccines Immunization Immunity Drug Development 179

STAT

OCTOBER 29, 2024

based companies from scratch to test and ultimately seek to commercialize innovative drugs developed in China. companies have long signed licensing deals with Chinese drugmakers. But increasingly American venture capitalists are building U.S.-based

Drug Development 348

Drug Development 348

STAT

MARCH 3, 2025

The obesity medicine field has gained a new entrant, with AbbVie on Monday announcing it had licensed an experimental weight loss drug from a Danish company that is in a Phase 1 trial.    The deal includes a $350 million upfront payment to the company, Gubra, for the rights to its drug, called for now GUB014295.

Drug Development 182

Drug Development 182

STAT

JANUARY 10, 2025

Vineeta Agarwala, a partner at Andreesen’s biotech arm, a16z Bio + Health, said the deal aims to combine “bleeding edge technology” in drug development from entrepreneurs with the “extraordinary depth in R&D experience” from Lilly’s executives.

Drug Development 363

Drug Development 363

Pharmacy Times

JUNE 19, 2025

SHOW MORE With robust pipelines, cell therapy remains the major driver for drug development. The field is expanding into autoimmune diseases, with nononcology trials representing 51% of the pipeline by late 2024.

Pharmacy Technician 26

Pharmacy Technician Diabetes Compounding Compounding Pharmacies 26

The Nontraditional Pharmacist

JULY 1, 2025

And there’s master’s programs, for example, I have an academic appointment at University of Cincinnati and they have a master’s of drug development program, which is fantastic. And the other thing I would say that helps is there’s certificate programs many universities offer.

Hospitals 52

Hospitals Packaging Documentation Labelling 52

Pharmacy Times

JULY 11, 2025

Complete response letters, which indicate reasons why a drug could not be approved in its current form, offer insightful information to drug developers on the inner mechanisms of the FDA’s approval process.

Drug Development 26

Drug Development 26